Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen. Read more about Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen.
2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway. Read more about 2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.
A small molecule that preferentially binds the closed conformation of Hsp90. Read more about A small molecule that preferentially binds the closed conformation of Hsp90.
Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells. Read more about Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells.
Robust in-gel fluorescence detection of mucin-type O-linked glycosylation. Read more about Robust in-gel fluorescence detection of mucin-type O-linked glycosylation.
Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction. Read more about Improved synthesis of 15-deoxyspergualin analogs using the Ugi multi-component reaction.
Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1. Read more about Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1.
Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists. Read more about Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.
Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists. Read more about Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists.
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. Read more about Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases.
